Portea Medical Expands Cancer Care Services Across India

New Delhi, August 6, 2025 — Portea Medical, India’s leading home healthcare provider, has announced the nationwide expansion of its comprehensive cancer care services. The initiative aims to ease access for oncology patients by offering treatment, monitoring, and palliative care at home — a significant relief for patients undergoing chemotherapy, radiotherapy, and post-treatment support.

This move comes as India witnesses a sharp rise in cancer cases. The need for decentralized, home-based services is more urgent than ever. According to the Indian Council of Medical Research (ICMR), India is projected to witness over 15 lakh new cancer cases in 2025. Many patients, particularly those in Tier 2 and Tier 3 cities, lack access to continuous, affordable, and high-quality cancer care.

Services Now Offered Across Cities

Portea Medical will now provide services in Delhi NCR, Bengaluru, Hyderabad, Chennai, Mumbai, and several smaller towns. These include:

  • Chemotherapy and medication administration

  • IV infusions and wound care

  • Nutrition counseling

  • Pain management

  • Oncologist-led virtual consultations

  • Emotional support and palliative care

The model has been piloted over the last year and, after positive outcomes and feedback, is now being scaled up.

Why It Matters

Cancer treatment is often long, exhausting, and disruptive. Families face financial and emotional stress. Traveling to hospitals multiple times weekly is painful — especially for terminally ill or elderly patients.

Home-based models are known to improve treatment compliance, reduce hospital-acquired infections, and help patients maintain dignity during advanced stages.

Dr. Vishal Sehgal, President of Portea Medical, said, “We want to bring compassionate care to patients’ doorsteps. Cancer is not just a medical battle — it’s a mental and emotional journey. Our teams are trained to support families throughout.”

Dr. Rajesh Chopra, senior oncologist at Max Healthcare, welcomed the initiative. “This aligns with global standards where home infusion therapy and palliative care are integral. India needs more such models, particularly in semi-urban regions.”

While India’s National Cancer Grid and public hospitals have expanded infrastructure, access remains unequal. Tele-oncology and home health tech platforms are being seen as the next wave in patient-centered cancer treatment.

According to Frost & Sullivan, India’s home healthcare market is expected to reach ₹7,000 crore by 2026, driven largely by chronic diseases like cancer, diabetes, and heart conditions.

Portea Medical’s initiative is expected to serve over 20,000 oncology patients in the next 12 months.

For full details, visit: medicarepharmabusiness.com

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg